INNOVIVA, INC.

INVA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $134.3M $59.5M $-18.8M $-168.5M $-170.7M $-18.5M $-115.3M $-83.9M
Depreciation & Amortization $14.0M $14.0M $13.9M $12.2M $3.5M $3.3M $7.6M $6.3M
Depreciation $200.0K $100.0K $100.0K $1.1M $2.7M $3.3M $3.8M $3.9M
Amortization $743.0K $0 $0
Stock-Based Compensation $9.8M $8.3M $6.9M $27.4M $25.7M $23.8M $24.9M $19.0M
Net Cash from Operating Activities $141.7M $61.0M $10.1M $-130.7M $-129.6M $-127.5M $-88.3M $-75.1M
Investing Activities
Capital Expenditures $0 $278.0K $7.0K $689.0K $2.7M $2.6M $3.6M $861.0K
Business Acquisitions
Net Cash from Investing Activities $-23.2M $-4.6M $159.2M $-65.1M $-219.6M $-58.3M
Financing Activities
Dividends Paid $281.0K $960.0K $87.3M $57.0M $0 $0
Stock Repurchases $97.5M $78.1M $25.6M $0 $0
Net Cash from Financing Activities $-163.2M $-97.6M $-106.9M $149.1M $397.8M $235.9M
Net Change in Cash $-44.7M $-41.2M $62.4M $-46.7M $48.7M $50.1M
Free Cash Flow $141.7M $60.7M $10.1M $-131.4M $-132.3M $-130.1M $-92.0M $-76.0M
← Newer Page 2 of 3 Older →